Revenue, Receivables, and Concentration of Credit Risk (Details) - Medicare Advantage Payors	3 Months Ended		12 Months Ended
	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025
Revenue from Contract with Customer Benchmark | Medical services revenue
Concentration Risk [Line Items]
Change in revenue recognized	1.00%	1.00%
Revenue from Contract with Customer Benchmark | Payor A
Concentration Risk [Line Items]
Concentration risk, percentage	22.00%	17.00%
Revenue from Contract with Customer Benchmark | Payor B
Concentration Risk [Line Items]
Concentration risk, percentage	24.00%	17.00%
Revenue from Contract with Customer Benchmark | Payor C
Concentration Risk [Line Items]
Concentration risk, percentage		11.00%
Revenue from Contract with Customer Benchmark | Payor E
Concentration Risk [Line Items]
Concentration risk, percentage	10.00%
Receivables | Payor A
Concentration Risk [Line Items]
Concentration risk, percentage	17.00%
Receivables | Payor B
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%
Receivables | Payor C
Concentration Risk [Line Items]
Concentration risk, percentage			15.00%
Receivables | Payor D
Concentration Risk [Line Items]
Concentration risk, percentage	13.00%		18.00%
Receivables | Payor E
Concentration Risk [Line Items]
Concentration risk, percentage	13.00%		10.00%
Receivables | Payor F
Concentration Risk [Line Items]
Concentration risk, percentage			14.00%